Confirmation study of immunostimulation effects by test-food intake - Confirmation study of immunostimulation effects by test-food intake

CPCC Company Limited0 sites30 target enrollmentSeptember 29, 2021

Overview

Phase: 未知
Intervention: Not specified
Conditions: Not specified
Sponsor: CPCC Company Limited
Enrollment: 30
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

September 29, 2021

End Date

December 8, 2020

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

CPCC Company Limited

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•(1\) Volunteers with influenza\-virus infection within a year before giving informed consent to take part in this trial. (2\) Volunteers with influenza vaccination recently at the point of giving informed consent to take part in this trial. (3\) Volunteers with previous history of some kind of symptom just like anaphylactic shock, which was caused by influenza vaccination. (4\) Volunteers taking steadily in the medicine, which might affect the test results. (5\) All through this trial, volunteers who have any difficulty in refraining from taking steadily in the health\-specific/functional/health foods, which might affect the test results. (6\) Pregnant, possibly pregnant, or lactating women. (7\) Volunteers with present/previous medical history of serious diseases in heart, liver, kidney and/or digestive organs. (8\) Volunteers with excessive alcohol intake. (9\) Volunteers with heavy smoking. (10\) Volunteers with extremely irregular life rhythms, midnight work and/or irregular shift one. (11\) Volunteers with drug and/or food allergy. (12\) Volunteers who are now under the other clinical tests with some kind of medicines/foods, or took part in those tests within four weeks after this trial. (13\) Volunteers who donated over 200 mL of their whole blood and/or blood components within a month into this trial. (14\) Males who donated over 400 mL of their whole blood within the last three months into this trial. (15\) Females who donated over 400 mL of their whole blood within the last four months into this trial. (16\) Males who will be collected over 1200 mL in total of their blood within the last twelve months, after adding the planned sampling blood amounts in this trial. (17\) Females who will be collected over 800 mL in total of their blood within the last twelve months, after adding the planned sampling blood amounts in this trial. (18\) Others who have been determined as ineligible for participation, according to the principal/sub investigator's opinions.